Aushon BioSystems

Aushon BioSystems provides comprehensive and robust protein biomarker assay development, detection and analysis through an innovative, cost-effective multiplex immunoassay platform that delivers exceptional performance, quality and reliability to accelerate pre-clinical and clinical biomarker research. With a growing menu of more than 300 biomarkers in key therapeutic areas, and advanced microarray printing technology, their broad suite of products and services offers a unique and complete solution for their customers – global leaders in the pharmaceutical, biotechnology, academic and diagnostic industries. They trust us to provide the most reliable protein biomarker data available, in the least amount of time, to lower their costs and improve research productivity.

Aushon BioSystems headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Health Diagnostics sector. The company focuses on Biotechnology and has secured $3.1B in funding across 84 round(s). With a team of 11-50 employees, Aushon BioSystems is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Aushon BioSystems, raised $2.0M. Discover more about their projects, partnerships, and impact on our platform.